Is Guardant Health (GH) Outperforming Other Medical Stocks This Year?

Group 1 - Guardant Health (GH) is currently outperforming its Medical peers with a year-to-date return of 38.9%, compared to the average gain of 6.2% for Medical stocks [4] - The Zacks Consensus Estimate for GH's full-year earnings has increased by 4% over the past quarter, indicating stronger analyst sentiment and an improving earnings outlook [4] - Guardant Health is ranked 2 (Buy) in the Zacks Rank system, which highlights stocks with characteristics likely to outperform the market in the next one to three months [3] Group 2 - Guardant Health is part of the Medical - Biomedical and Genetics industry, which consists of 510 companies and is currently ranked 66 in the Zacks Industry Rank [6] - The Medical - Biomedical and Genetics industry has gained an average of 7% year-to-date, indicating that Guardant Health is performing better than its industry peers [6] - Brookdale Senior Living (BKD) is another Medical stock that has outperformed its sector with a year-to-date return of 12.1% and also holds a Zacks Rank of 2 (Buy) [5]